What did the economic evaluation of the FAIR-HF trial find regarding IV iron supplementation compared to no iron supplementation for people with HF and iron deficiency?
The economic evaluation of the FAIR-HF trial found that IV iron supplementation increased costs and improved health (increased QALYs) compared with no iron supplementation with an incremental cost- effectiveness ratio of 3,977 per QALY gained. The probability that IV iron is cost effective at the 20,000 per QALY threshold was around 99%.